Press-release for stocks related to bioscience for ensysce biosciences inc

Prices are updated after-hours

Ensysce Biosciences Announces Participation in the 34th Annual Roth Conference
Published: 2022-02-23 (Crawled : 18:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K

| -99.78% | O: 2.86% H: 5.56% C: -1.85%
conference bioscience

Ensysce Biosciences Appoints Industry Veteran Lee Rauch to Board of Directors
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
ENSC | $0.5497 1.61% 1.58% 44K

| -99.86% | O: 1.23% H: 4.88% C: 4.88%
ces bioscience

Ensysce Biosciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
Published: 2022-01-31 (Crawled : 23:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K

| -99.86% | O: 3.59% H: 5.41% C: 0.58%
ces program bioscience communication group communications

Ensysce Biosciences Announces Results of Special Meeting of Stockholders
Published: 2022-01-27 (Crawled : 14:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K

| -99.87% | O: 0.55% H: 5.46% C: -9.84%
bioscience

| -99.95% | O: 4.43% H: 4.23% C: -8.93%
pf614 trial opioid bioscience

| -99.94% | O: -1.95% H: 0.5% C: -18.86%
pf614 unique technology phase 1 opioid bioscience platform enroll

Ensysce Biosciences Announces Clinical Trial Progress of its New Class of Opioids
Published: 2021-11-30 (Crawled : 15:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K

| -64.78% | O: 2.83% H: 0.0% C: 0.0%
trial opioid bioscience

Ensysce Biosciences Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
Published: 2021-11-15 (Crawled : 23:00) - globenewswire.com
ENSC | $0.5497 1.61% 1.58% 44K

| -73.83% | O: -6.07% H: 1.62% C: -24.63%
financial results results bioscience

Ensysce Biosciences Announces Completion of $15 Million Convertible Note Financing
Published: 2021-11-08 (Crawled : 13:15) - globenewswire.com
ENSC | $0.5497 1.61% 1.58% 44K

| -75.49% | O: -0.22% H: 0.0% C: -2.19%
bioscience

Ensysce Biosciences Grows its Management Team with Appointment of Dr. Linda Pestano as Chief Development Officer
Published: 2021-10-26 (Crawled : 18:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K

| -74.31% | O: -2.75% H: 0.0% C: 0.0%
pest bioscience

Ensysce Biosciences Announces $15 Million Convertible Note Financing
Published: 2021-09-27 (Crawled : 18:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K

| -87.53% | O: -7.13% H: 4.32% C: -5.04%
bioscience

Ensysce Biosciences Sets September 2021 Conference Schedule
Published: 2021-08-31 (Crawled : 13:00) - biospace.com/
ENSC | $0.5497 1.61% 1.58% 44K

| -81.76% | O: -0.65% H: 7.54% C: 3.61%
conference set bioscience

Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
Published: 2021-08-16 (Crawled : 23:00) - globenewswire.com
ENSC | $0.5497 1.61% 1.58% 44K

| -80.69% | O: -0.69% H: 25.69% C: 19.79%
financial results results bioscience

Ensysce Biosciences to Host Virtual Investor Day on July 27, 2021
Published: 2021-07-21 (Crawled : 12:00) - globenewswire.com
ENSC | $0.5497 1.61% 1.58% 44K

| -93.02% | O: -6.48% H: 12.05% C: -5.33%
bioscience